Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Application of ethyl asterrate in preparation of anti-alzheimer medicine

A technology for senile dementia and drugs, applied in the field of medicine, can solve problems such as no reports of compounds

Inactive Publication Date: 2014-05-07
YICHUN UNIVERSITY
View PDF1 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Compound ethyl asterrate in the present invention is the derivant of kodiic acid, has remarkable antibacterial activity (LI Y, SUN BD, CHE YS, et al.Bioactive Asterric acid derivatives from the Antarctic ascomycete fungus Geomyces sp. [J]. J Nat Prod, 2008, 71( 9): 1643~1646. ), but there is no report on the inhibitory activity of this type of compound on acetylcholinesterase

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of ethyl asterrate in preparation of anti-alzheimer medicine
  • Application of ethyl asterrate in preparation of anti-alzheimer medicine
  • Application of ethyl asterrate in preparation of anti-alzheimer medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0011] Example 1: Acetylcholinesterase inhibitory activity of the compound ethyl asterrate

[0012] (1) Drugs and reagents

[0013] Acetylcholinesterase (AChE, Sigma Company), 50 mmol / L, pH8.0 phosphate-buffered saline (PBS), 15 mmol / L 5,5-dithio-2-nitrobenzoic acid (dithiobis-nitrobenzoic acid , DTNB) solution (Sigma company) (prepared with 50mmol / L, pH 8.0 PBS), 15 mmol / L thioacetylcholine (Acetyl thiocholine, ATch, Sigma company, prepared with 50mmol / L, pH 8.0 PBS), 4% ten Sodium Dialkyl Sulfate (SDS, Sigma Company), positive control Huperzine A (National Institute for the Control of Pharmaceutical and Biological Products), 0.75mol / L MgCl 2 solution, methanol.

[0014] (2) Experimental method

[0015] Refer to the literature (Zhang Yi, Feng Yan, Li Xiaoming, et al. Research on the inhibition of acetylcholinesterase activity by seaweed components [J]. Ocean and Limnology, 2005, 36(5): 459-464.) and make appropriate improvements. The reference substance for the detectio...

Embodiment 2

[0023] (1) Experimental animals and test drugs

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of ethyl asterrate in preparation of an anti-alzheimer medicine, and in particular relates to application of diphenyl ether compound ethyl asterrate shown in the structural formula (I) in inhibition of the activity of acetylcholine esterase and preparation of an anti-alzheimer medicine. Experiments prove that the ethyl asterrate can remarkably inhibit the activity of acetylcholine esterase, can remarkably improve the memory and space exploration capability of an alzheimer rat model caused by D-galactose and AlCl3, can be applied to preparation of the anti-alzheimer medicine, and indicates an excellent market application prospect.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to a diphenyl ether compound, and its acetylcholinesterase inhibitory activity is studied. The compound can be applied to the preparation of anti-senile dementia drugs. Background technique [0002] Alzheimer's disease (AD) is a progressive neurodegenerative disease, which is mainly manifested as memory function attenuation and recognition impairment, accompanied by various neurological symptoms and behavioral disorders, and has a very high incidence rate. Currently, the market approves the treatment of AD Most of the drugs used are drugs that inhibit the activity of acetylcholinesterase, mainly including tacrine, donepezil, carbamates (such as rivastigmine, revosidamine), huperzine A, galantamine (galantamine) etc. With the arrival of the aging of the global population, the number of its incidence will continue to increase, and the demand for anti-senile dementia drugs will hav...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/60A61P25/28
Inventor 颜日明朱笃汪涯张志斌汪娣
Owner YICHUN UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com